Eugia USFDA 483 Cites Inadequate Contain
Aurobindo arm, Eugia Pharma Specialities facility at Bhiwadi, Rajasthan was issued USFDA 483 with seven
Warning letters, 483s, Recalls, Import Alerts, Audit observations
Aurobindo arm, Eugia Pharma Specialities facility at Bhiwadi, Rajasthan was issued USFDA 483 with seven
USFDA inspection of Zydus Life sciences, Vadodara facility resulted in USFDA 483 with 10 observations.
Aurobindo arm Eugia Pharma site at Sangareddy, Telengana was inspected by USFDA in Jan -Feb
USFDA issued a Warning letter to Intas, Matoda, Ahmedabad facility on 21 November 2023. This
Intas facility was inspected by FDA investigators Jose E Melendez, Justin A Boyd, Pratik S
FDA published the USFDA483 issued to Intas site (FEI 3003157498) in Ahmedabad, India after inspection